Eureka Therapeutics, Memorial Sloan Kettering, Juno Therapeutics deal

Memorial Sloan and Eureka granted Juno exclusive, worldwide rights to binding domains

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE